Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > News > Big Pharma Is Missing the Nanotechnology Opportunity

February 15th, 2005

Big Pharma Is Missing the Nanotechnology Opportunity

Abstract:
The U.S. National Institutes of Health counts nanomedicine as one of its top five priorities, the National Cancer Institute committed $144 million to nanotechnology research in October 2004, and 40% of nanotech venture capital since 1998 has gone to life sciences start-ups. Yet despite nanotechnology's promise in improving how drugs are developed and delivered, major pharmaceutical companies are committing almost
no money or people to nanotechnology research -- exposing them to strategic
risks, according to a new report from Lux Research entitled "Why Big Pharma Is
Missing the Nanotech Opportunity."

Source:
prnewswire

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

SentiMag® Now Available in Australia and New Zealand July 21st, 2014

More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE